Biocare Medical reagents and antibodies were recently utilized in a study by researchers at Tufts University and published in Nature Medicine, reviewing an experimental SARS-Cov-2 vaccine’s efficacy. Using the Biocare intelliPATH FLX instrument with MACH2 Detection, Background Eraser, and Microglia antibody, researchers tracked viral replication and disease symptoms in hamsters administered high-dose intranasal SARS-CoV-2 infection both with and without immunization with the experimental vaccine. Biocare is very proud to continue to contribute its part in the fight against SARS-CoV-2!
Learn More by Reading the Nature Medicine Article Below:
Learn More About intelliPATH FLX:
Learn More About MACH2 Detection:
Learn More About Background Eraser:
Learn More About Microglia Antibody: